Sven Eisold
Impact in
-
- Pancreatic and Hepatic Oncology Research
- CAR-T cell therapy research
-
- Cancer Research and Treatments
Papers in
- Co-authors
- Jan Schmidt (7 shared papers)Michael Linnebacher (10 shared papers)Eduard Ryschich (5 shared papers)Magnus von Knebel Doeberitz (6 shared papers)Guido Alsfasser (2 shared papers)Julien Schmidt (1 shared paper)Margot Zöller (2 shared papers)Karin Haack (2 shared papers)
- Journals
- Cancer Gene Therapy (2 papers)RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren (1 paper)Pancreas (1 paper)Cancer Immunology Immunotherapy (1 paper)Cancer (1 paper)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Sven Eisold
21 papers receiving 223 citations
Peers
Comparison fields: 5 of 44
- Oncology 105
- Biotechnology 30
- Immunology 61
- Transplantation 4
- Genetics 37
Countries citing papers authored by Sven Eisold
This map shows the geographic impact of Sven Eisold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven Eisold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven Eisold more than expected).
Fields of papers citing papers by Sven Eisold
This network shows the impact of papers produced by Sven Eisold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven Eisold. The network helps show where Sven Eisold may publish in the future.
Co-authors
The 25 scholars most cited alongside Sven Eisold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 38 | |
| 2 | 2003 | 27 | |
| 3 | 2004 | 26 | |
| 4 | 2012 | 24 | |
| 5 | 2000 | 21 | |
| 6 | 2002 | 13 | |
| 7 | 2006 | 11 | |
| 8 | 2009 | 8 | |
| 9 | 2004 | 8 | |
| 10 | 2008 | 8 | |
| 11 | 2007 | 7 | |
| 12 | 2000 | 6 | |
| 13 | 2011 | 6 | |
| 14 | 2000 | 5 | |
| 15 | 2009 | 5 | |
| 16 | 2014 | 4 | |
| 17 | 2006 | 3 | |
| 18 | 2002 | 3 | |
| 19 | Influence of Chemotherapeutic Treatment on Expression of Human Multidrug Resistance Protein (ABCC, ABCB) Family Members in Pancreatic Cancer Cell Lines | 2013 | 2 |
| 20 | 1996 | 1 |
About Sven Eisold
Sven Eisold is a scholar working on Oncology, Genetics, Molecular Biology, Surgery and Epidemiology, having authored 21 papers that have together received 227 indexed citations. Recurring topics across this work include CAR-T cell therapy research (5 papers), Virus-based gene therapy research (5 papers), RNA Interference and Gene Delivery (3 papers), Pancreatic and Hepatic Oncology Research (2 papers), Immunotherapy and Immune Responses (2 papers), T-cell and B-cell Immunology (2 papers), Neuroendocrine Tumor Research Advances (2 papers) and Sarcoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Oncology (105 citations), Biotechnology (30 citations), Immunology (61 citations), Transplantation (4 citations) and Genetics (37 citations). Sven Eisold has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Jan Schmidt, Michael Linnebacher, Eduard Ryschich, Magnus von Knebel Doeberitz, Guido Alsfasser, Julien Schmidt, Margot Zöller, Karin Haack, Frank Autschbach and Johannes Gebert. Their work appears in journals such as Cancer Gene Therapy, RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, Pancreas, Cancer Immunology Immunotherapy and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.